NASDAQ:CNMD CONMED - CNMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. $99.87 -2.74 (-2.67%) (As of 02/6/2023 12:00 AM ET) Add Compare Share Share Today's Range$98.86▼$101.9750-Day Range N/A52-Week Range$71.09▼$155.51Volume480,620 shsAverage Volume480,804 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsOptions ChainSEC FilingsSocial Media About CONMEDCONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States, Americas excluding the United States, Europe, Middle East, and Africa, and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.Read More Receive CNMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter. Email Address CNMD Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CNMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter. Email Address CNMD Company Calendar Today2/06/2023Next Earnings2/06/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical Specialties Sub-IndustryN/A SectorHealth Technology Current SymbolNASDAQ:CNMD CUSIPN/A CIK816956 WebN/A Phone(727) 392-6464FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A Key ExecutivesCurt R. HartmanChairman, President & Chief Executive OfficerTodd W. GarnerChief Financial Officer & Executive Vice PresidentShanna L. Cotti-OsmanskiChief Information Officer & Executive VP-ITHeather L. CohenEVP, Chief Human Resources & Legal OfficerTerence M. BergéVice President & ControllerKey CompetitorsAstraZenecaNYSE:AZNView All Competitors CNMD Stock - Frequently Asked Questions When is CONMED's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023. View our CNMD earnings forecast. What other stocks do shareholders of CONMED own? Based on aggregate information from My MarketBeat watchlists, some companies that other CONMED investors own include AbbVie (ABBV), Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), AT&T (T), Abbott Laboratories (ABT), Bank of America (BAC), Bausch Health Companies (BHC) and General Mills (GIS). What is CONMED's stock symbol? CONMED trades on the NASDAQ under the ticker symbol "CNMD." How do I buy shares of CONMED? Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. How can I contact CONMED? The company can be reached via phone at (727) 392-6464. This page (NASDAQ:CNMD) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.